Read + Share
Amedeo Smart
Independent Medical Education
Ye Z, Zeng Y, Wei S, Wang Y, et al. Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer. BMC Cancer 2021;21:702.PMID: 34126957
Email
LinkedIn
Facebook
Twitter
Privacy Policy